These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 34340244)
21. Editorial commentary: COVID-19 as a cardiovascular disease risk factor. Oktay AA; Suboc TM; Volgman AS Trends Cardiovasc Med; 2022 Nov; 32(8):476-478. PubMed ID: 35850405 [No Abstract] [Full Text] [Related]
22. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry. Gómez-Mesa JE; Galindo-Coral S; Montes MC; Alarco W; Barisani JL; Magaña A; Perna ER; Romero A; Speranza M; Mendoza I; Wyss F Glob Heart; 2021 Feb; 16(1):14. PubMed ID: 33833938 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular system and COVID-19: perspectives from a developing country. Kunal S; Gupta K; Sharma SM; Pathak V; Mittal S; Tarke C Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32380802 [TBL] [Abstract][Full Text] [Related]
24. Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality. Li G; Saguner AM; An J; Ning Y; Day JD; Ding L; Waintraub X; Wang J Cardiol J; 2020; 27(5):616-624. PubMed ID: 32789839 [TBL] [Abstract][Full Text] [Related]
25. Acute and Subclinical Myocardial Injury in COVID-19. Crudo VL; Ahmed AI; Cowan EL; Shah DJ; Al-Mallah MH; Malahfji M Methodist Debakey Cardiovasc J; 2021; 17(5):22-30. PubMed ID: 34992721 [TBL] [Abstract][Full Text] [Related]
26. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108 [TBL] [Abstract][Full Text] [Related]
27. Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality. Aleksova A; Fluca AL; Gagno G; Pierri A; Padoan L; Derin A; Moretti R; Noveska EA; Azzalini E; D'Errico S; Beltrami AP; Zumla A; Ippolito G; Sinagra G; Janjusevic M Life Sci; 2022 Dec; 310():121018. PubMed ID: 36183780 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular impact of COVID-19: an array of presentations. Maab H; Mustafa F; Shabbir SJ Acta Biomed; 2021 May; 92(2):e2021021. PubMed ID: 33988162 [TBL] [Abstract][Full Text] [Related]
29. Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies. Samidurai A; Das A Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947927 [TBL] [Abstract][Full Text] [Related]
38. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries. Li N; Zhu L; Sun L; Shao G Stem Cell Res; 2021 Mar; 51():102168. PubMed ID: 33485182 [TBL] [Abstract][Full Text] [Related]
39. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era. Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P; Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501 [TBL] [Abstract][Full Text] [Related]